Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New endovascular prosthesis is promising for non-surgical treatment of TAAs

06.08.2002


Research study shows promising results for non-surgical treatment of life threatening condition



Rodney White, MD, Chief of Vascular Surgery and Associate Chair, Department of Surgery at Harbor-UCLA Medical Center and Principal Investigator at the Research & Education Institute at Harbor-UCLA Medical Center (REI) is shedding new light on endovascular treatment of thoracic aortic aneurysms (TAAs). A life threatening condition caused by a weakening of the vascular wall of the aorta in the chest, TAAs can lead to either sudden death or death in a matter of hours if the aorta ruptures.

In an REI clinical study, Dr. White and a team of cardiovascular surgeons, radiologists and scientists have successfully treated approximately 60 patients over the last three years with thoracic aortic aneurysms, aortic dissections and other cause of acute rupture. REI and the Harbor-UCLA Medical Center hold the distinction of being the only study site in the Los Angeles area to conduct this FDA-approved Investigational Device Exemption (IDE) research. Results on the first 25 patients in this study were published in the Journal of Vascular Surgery, May 2001. Dr. White and his team are a part of a nationwide referral network that has also implanted endovascular prostheses into approximately 600 patients diagnosed with abdominal aortic aneurysms, the 13th leading cause of death in the United States.


Dr. White, a graduate of the State University of New York Upstate Medical Center, believes that this research holds much promise.

"With the development of endovascular prostheses to treat abdominal aortic aneurysms in the mid 1990’s, a concomitant effort to adapt this technology to the treatment of thoracic aneurysms has demonstrated promising preliminary results with a decrease in both major morbidity and mortality being noted in many patients," he says.

The new technology also makes repair of thoracic aortic aneurysms and dissections available to patients who are not considered to be reasonable candidates for conventional surgical repair. "Although the experience is preliminary, the magnitude of the conventional surgical procedure and the decreased incidence of morbidity and mortality with endovascular repairs support further evaluation of this technology," he adds.



The Research & Education Institute at Harbor-UCLA Medical Center, located on the campus of Harbor-UCLA Medical Center near Torrance, California, is a leading independent, not-for-profit biomedical research institute with an international reputation for scientific discovery, the training of physician-scientists and the provision of community service programs. It is an affiliate of both the David Geffen School of Medicine at UCLA and the Harbor-UCLA Medical Center and has an annual budget of $58 million. The Institute traces its roots back to 1952, when researchers and physicians joined forces with the UCLA School of Medicine on the campus of what was then known as Harbor General Hospital to conduct a handful of research studies. Today, more than 1,000 research projects and clinical trials are being conducted at REI, advancing scientific understanding in order to improve medical outcomes and promote innovation in such areas as autoimmune disorders, cancer, cardiovascular disease, developmental disorders and other pediatric health problems, diabetes, infectious disease, inherited disorders, male contraception, vaccine evaluation and research, and various aspects of women’s health.


Barbara T. Kerr | EurekAlert!
Further information:
http://www.rei.edu/

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>